Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis

In patients with a recent transient ischemic attack or stroke attributed to 70 to 99% stenosis of a major intracranial artery, aggressive medical management was superior to aggressive medical management plus percutaneous transluminal angioplasty and stenting. Atherosclerotic intracranial arterial st...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2011-09, Vol.365 (11), p.993-1003
Hauptverfasser: Chimowitz, Marc I, Lynn, Michael J, Derdeyn, Colin P, Turan, Tanya N, Fiorella, David, Lane, Bethany F, Janis, L. Scott, Lutsep, Helmi L, Barnwell, Stanley L, Waters, Michael F, Hoh, Brian L, Hourihane, J. Maurice, Levy, Elad I, Alexandrov, Andrei V, Harrigan, Mark R, Chiu, David, Klucznik, Richard P, Clark, Joni M, McDougall, Cameron G, Johnson, Mark D, Pride, G. Lee, Torbey, Michel T, Zaidat, Osama O, Rumboldt, Zoran, Cloft, Harry J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In patients with a recent transient ischemic attack or stroke attributed to 70 to 99% stenosis of a major intracranial artery, aggressive medical management was superior to aggressive medical management plus percutaneous transluminal angioplasty and stenting. Atherosclerotic intracranial arterial stenosis is one of the most common causes of stroke worldwide 1 – 6 and is associated with a high risk of recurrent stroke. 7 – 9 Patients with a recent transient ischemic attack (TIA) or stroke and severe stenosis (70 to 99% of the diameter of a major intracranial artery) are at particularly high risk for recurrent stroke in the territory of the stenotic artery (approximately 23% at 1 year) despite treatment with aspirin and standard management of vascular risk factors. 8 , 10 Therefore, alternative therapies are urgently needed for these patients. Two strategies have emerged for the treatment of high-risk . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1105335